Therefore, we examined whether concurrent torsinA KD in the cerebellum and basal ganglia would result in more severe symptoms. We found that knockdown of torsinA in the cerebellum and basal ganglia did not enhance the severity of dystonia when compared to mice with torsinA KD in the cerebellum alone (Figure 1—figure supplement 2). The gene discussed is TOR1A; the disease is Dystonia.